Botanix Pharmaceuticals Limited
BXPHF
$0.25
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -290.08% | -176.78% | -47.71% | -11.89% | 15.57% |
| Total Depreciation and Amortization | 1,035.32% | 485.89% | -36.06% | -16.33% | 8.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -57.09% | 4.00% | 179.02% | 849.08% | 259.06% |
| Change in Net Operating Assets | 127.33% | 127.33% | 127.33% | -8.28% | -383.25% |
| Cash from Operations | -242.14% | -93.71% | 34.43% | 28.04% | 21.23% |
| Capital Expenditure | -333.86% | -508.55% | -1,350.98% | -1,055.81% | -625.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.45% | 8.76% | -147.06% | -120.50% | -98.06% |
| Cash from Investing | 75.50% | 7.76% | -148.36% | -121.27% | -98.39% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -90.12% | 96.93% | -- | 99.19% | 98.40% |
| Issuance of Common Stock | 89.73% | 180.13% | 327.53% | 276.02% | 185.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -90.54% | -173.60% | -300.21% | -251.37% | -166.12% |
| Cash from Financing | 89.45% | 179.06% | 321.40% | 270.82% | 185.80% |
| Foreign Exchange rate Adjustments | 106.12% | 83.57% | 30.68% | 223.96% | 165.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 213.31% | 682.15% | 2,175.12% | 1,436.92% | 206.50% |
